TY - JOUR
T1 - Maximizing the benefits of antiviral therapy for HCV
T2 - The advantages of treating side effects
AU - Gish, Robert G.
PY - 2004/3
Y1 - 2004/3
KW - Hepatitis C/drug therapy
KW - Antiviral Agents/adverse effects
KW - Humans
KW - Interferons/adverse effects
KW - Ribavirin/adverse effects
KW - Practice Guidelines as Topic
UR - https://www.scopus.com/pages/publications/1842715128
UR - https://www.scopus.com/pages/publications/1842715128#tab=citedBy
UR - https://www.mendeley.com/catalogue/9c6fc2d6-6940-3bf8-98af-dbf7c2251256/
U2 - 10.1016/j.gtc.2004.01.001
DO - 10.1016/j.gtc.2004.01.001
M3 - Editorial
C2 - 15081104
AN - SCOPUS:1842715128
SN - 0889-8553
VL - 33
SP - xxiii-xxiv
JO - Gastroenterology Clinics of North America
JF - Gastroenterology Clinics of North America
IS - 1 SUPPL.
ER -